UroGen Pharma Ltd. - URGN

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$853.6M

QoQ value delta ($000)

-$211M (-19.82%)

Implied price effect (QoQ)

-22.98%

Total shares

47,332,436

QoQ shares delta

+1,865,362 (+4.1%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 174 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
RTW INVESTMENTS, LP	81,699	4,543,895	0.81%
BlackRock, Inc.	51,163	2,845,567	0.0%
TORONTO DOMINION BANK	47,048	2,616,714	0.07%
MORGAN STANLEY	46,029	2,560,038	0.0%
Kynam Capital Management, LP	40,408	2,247,393	2.49%
Jefferies Financial Group Inc.	39,549	2,199,652	0.27%
Paradigm Biocapital Advisors LP	30,637	1,703,949	0.63%
ACORN CAPITAL ADVISORS, LLC	30,088	1,673,420	8.55%
SG Americas Securities, LLC	29,808	1,657,846	0.03%
AMERICAN CENTURY COMPANIES INC	29,443	1,637,570	0.02%
SILVERARC CAPITAL MANAGEMENT, LLC	27,024	1,503,045	2.76%
Opaleye Management Inc.	25,711	1,430,000	3.39%
FRONTIER CAPITAL MANAGEMENT CO LLC	23,627	1,314,112	0.24%
MENORA MIVTACHIM HOLDINGS LTD.	20,722	1,152,531	0.1%
D. E. Shaw & Co., Inc.	18,396	1,023,159	0.01%
J. Goldman & Co LP	17,779	988,870	0.52%
MPM BioImpact LLC	16,969	943,803	1.31%
ORBIMED ADVISORS LLC	15,741	875,487	0.31%
STATE STREET CORP	15,717	874,176	0.0%
Migdal Insurance & Financial Holdings Ltd.	13,860	770,909	0.12%
Soleus Capital Management, L.P.	13,071	727,000	0.53%
GOLDMAN SACHS GROUP INC	10,761	598,528	0.0%
VANGUARD GROUP INC	10,298	439,751	0.0%
GEODE CAPITAL MANAGEMENT, LLC	9,418	523,831	0.0%
Woodline Partners LP	9,003	500,726	0.03%